| Nome del prodotto |
Rizatriptan Benzoate |
| Nome inglese |
Rizatriptan Benzoate; MAXALT; RIZATRIPTANE BENZOATE; N,N-DIMETHYL-5-(1H-1,2,4-TRIAZOL-1-YLMETHYL)-1H-INDOLE-3-ETHANAMINE, BENZOATE; n,n-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1h-indol-3-yl]ethylamine benzoate; MK-0462; MK-462; Rizatrimptan Benzoate; N,N-dimethyl-2-[5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine; N,N-dimethy1-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine monobenzoate |
| Formula molecolare |
C15H19N5.C7H6O2 |
| Peso Molecolare |
391.47 |
| InChI |
InChI=1/C15H19N5/c1-19(2)6-5-13-8-17-15-4-3-12(7-14(13)15)9-20-11-16-10-18-20/h3-4,7-8,10-11,17H,5-6,9H2,1-2H3 |
| Numero CAS |
145202-66-0 |
| Struttura molecolare |
|
| Densità |
1.21g/cm3 |
| Punto di fusione |
178-180℃ |
| Punto di ebollizione |
504.8°C at 760 mmHg |
| Indice di rifrazione |
1.645 |
| Punto d'infiammabilità |
259.1°C |
| Pressione di vapore |
2.58E-10mmHg at 25°C |
|